Hot Chips - Parenteral Drugs
Jayashree / 05 Jul 2010
Parenteral Drugs India (PDIL) has recently set up a critical care division to market its product basket, including the Paracetamol-based IV fluid. The stock can be looked at for short to medium-term gain.
BSE Code: 524689
Volume: 230000
CMP: Rs 245.85
Parenteral Drugs India (PDIL) has recently set up a critical care division to market its product basket, including the Paracetamol-based IV fluid. PDIL targets peak revenues of Rs 150 crore from this in the next two years led by higher volumes and margins, high-end IV fluids like fat emulsions, amino acids, etc. and anesthesia under an exclusive distribution pact with Piramal Healthcare. Besides, it has also strategically diversified into oncology, UNOPS (United Nations Offices for Project Services) supply, etc. PDIL aims to treble its revenues from its oncology business in FY11E, led by robust sales in international markets. PDIL also aims at revenues of at least Rs 70 crore from its UNOPS’ orders in FY11E. The company is also expanding its geographical reach beyond the domestic borders through its international JVs in Mauritius, Kenya, Kazakhstan, etc. The stock can be looked at for short to medium-term gain.
If you want to stay updated with the share market news today, keep a close watch on the indian stock market today with real time movements like sensex today live and overall stock market today trends. Investors tracking ipo allotment status, ipo news today, or the latest ipo india can also follow daily updates along with bse share price live data. Whether you are learning how to invest in stock market in india, preparing for a market crash today, or searching for the best stocks to buy in india, insights on top gainers today india, top losers today india, trending stocks india and long term stocks india help in making informed investment decisions.